Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,445 | 10,672 | -11,827 | 73,865 | 58,537 |
| Depreciation Amortization | 64,520 | 40,635 | 19,309 | 82,237 | 64,066 |
| Income taxes - deferred | -13,797 | -11,152 | -3,990 | -20,136 | -20,064 |
| Accounts receivable | -5,885 | 1,246 | -3,563 | 2,078 | -1,253 |
| Other Working Capital | -28,702 | 20,498 | 9,006 | -2,052 | 3,077 |
| Other Operating Activity | 45,779 | 27,235 | 21,664 | 35,959 | 23,182 |
| Operating Cash Flow | $27,470 | $89,134 | $30,599 | $171,951 | $127,545 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 349,420 | 7,492 | 37,644 | -189,142 | -176,717 |
| PPE Investments | -911 | -782 | -327 | -725 | -512 |
| Net Acquisitions | -293,093 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $55,416 | $6,710 | $37,317 | $-189,867 | $-177,229 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,059 | 5,318 | 2,042 | 14,908 | 8,031 |
| Other Financing Activity | -28,455 | -25,782 | -23,441 | -2,715 | -1,728 |
| Financing Cash Flow | $604 | $-20,464 | $-21,399 | $12,193 | $6,303 |
| Beginning Cash Position | 69,331 | 69,331 | 69,331 | 75,054 | 75,054 |
| End Cash Position | 152,821 | 144,711 | 115,848 | 69,331 | 31,673 |
| Net Cash Flow | $83,490 | $75,380 | $46,517 | $-5,723 | $-43,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,470 | 89,134 | 30,599 | 171,951 | 127,545 |
| Capital Expenditure | -911 | -782 | -327 | -725 | -512 |
| Free Cash Flow | 26,559 | 88,352 | 30,272 | 171,226 | 127,033 |